Growth Metrics

Galectin Therapeutics (GALT) Shareholder's Equity (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 595,226.00
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 19.36 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 31.42 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1.08 Bn
10 Galectin Therapeutics 165.77 Mn 151.67 Mn - -131.96 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -131.96 Mn
Dec 31, 2025 -127.92 Mn
Sep 30, 2025 -125.30 Mn
Jun 30, 2025 -118.89 Mn
Mar 31, 2025 -113.98 Mn
Dec 31, 2024 -104.79 Mn
Sep 30, 2024 -94.20 Mn
Jun 30, 2024 -83.87 Mn
Mar 31, 2024 -44.37 Mn
Dec 31, 2023 -61.96 Mn
Sep 30, 2023 -52.60 Mn
Jun 30, 2023 -52.85 Mn
Mar 31, 2023 -44.37 Mn
Dec 31, 2022 -33.92 Mn
Sep 30, 2022 -24.06 Mn
Jun 30, 2022 -16.95 Mn
Mar 31, 2022 -7.92 Mn
Dec 31, 2021 893,000.00
Sep 30, 2021 7.53 Mn
Jun 30, 2021 15.39 Mn
Mar 31, 2021 16.51 Mn
Dec 31, 2020 22.47 Mn
Sep 30, 2020 29.82 Mn
Jun 30, 2020 35.29 Mn
Mar 31, 2020 41.03 Mn
Dec 31, 2019 43.87 Mn
Sep 30, 2019 47.76 Mn
Jun 30, 2019 49.90 Mn
Mar 31, 2019 5.12 Mn
Dec 31, 2018 5.18 Mn
Sep 30, 2018 7.25 Mn
Jun 30, 2018 8.05 Mn
Mar 31, 2018 925,000.00
Dec 31, 2017 -530,000.00
Sep 30, 2017 947,000.00
Jun 30, 2017 4.09 Mn
Mar 31, 2017 7.91 Mn
Dec 31, 2016 10.29 Mn
Sep 30, 2016 10.31 Mn
Jun 30, 2016 7.49 Mn
Mar 31, 2016 12.47 Mn
Dec 31, 2015 18.04 Mn
Sep 30, 2015 12.84 Mn
Jun 30, 2015 17.88 Mn
Mar 31, 2015 21.85 Mn
Dec 31, 2014 21.20 Mn
Sep 30, 2014 23.22 Mn
Jun 30, 2014 25.72 Mn
Mar 31, 2014 28.27 Mn
Dec 31, 2013 1.48 Mn
Sep 30, 2013 1.30 Mn
Jun 30, 2013 -3.09 Mn
Mar 31, 2013 -1.04 Mn
Dec 31, 2012 1.17 Mn
Sep 30, 2012 3.06 Mn
Jun 30, 2012 4.91 Mn
Mar 31, 2012 6.82 Mn
Dec 31, 2011 -2.13 Mn
Sep 30, 2011 823,000.00
Jun 30, 2011 915,000.00
Dec 31, 2010 -1.69 Mn